With respect to starting the Fragile X trial and the one undisclosed rate disease trial, one would surmise that there is very important data coming out of the Rett pediatric study relevant to the trial design of both. My guess is we wont have to run a safety trial in any more rare diseases and quite possibly one trial foreach disease ie having an age group from 5-35.
Do you (or anyone) recall how long it took to process and analyze the Avatar data or at least recall time from trial completion to data release? What timelines for data readout do we expect, surely not Febish….
News 
Market Data 
Discover 
AI
